State of Hawaii COVID-19 Vaccination Plan DRAFT
Total Page:16
File Type:pdf, Size:1020Kb
1 2 3 State of Hawaii COVID-19 Vaccination Plan DRAFT Hawaii Department of Health OCTOBER 16, 2020 | DRAFT VERSION 1.0 For Official Use Only (FOUO) 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 This Page Intentionally Left Blank Interim Draft FOUO 1 Record of Change 2 Date Reviewed Change Date of Change Description of Change Name of Author Number 3 4 5 6 7 Base Plan Record of Change INTERIM DRAFT ‐ FOUO i 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 This Page Intentionally Left Blank Base Plan Record of Change INTERIM DRAFT ‐ FOUO ii 1 Promulgation Statement 2 3 4 5 This COVID‐19 Vaccination Plan is hereby accepted for implementation and supersedes all previous editions. 6 7 8 9 10 11 12 13 _________________________ _________________________ 14 Elizabeth “Libby” Char, M.D. DATE 15 Hawaii Department of Health 16 Director 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 Base Plan Promulgation Statement INTERIM DRAFT ‐ FOUO iii 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 This Page Intentionally Left Blank 25 26 Base Plan Promulgation Statement INTERIM DRAFT ‐ FOUO iv Contents Record of Changes ....................................................................................................................................................... i Promulgation Document ........................................................................................................................................... iii Executive Summary ................................................................................................................................................ ES‐i 1 Situation .............................................................................................................................................................. 1‐1 1.1 Purpose ......................................................................................................................................................... 1‐1 1.2 Scope ............................................................................................................................................................ 1‐1 1.3 Situation Overview ....................................................................................................................................... 1‐2 1.3.1.1 Lessons Learned/Mitigation Strategies .............................................................................................. 1‐3 1.3.1.2 Exercise Plan ....................................................................................................................................... 1‐4 1.3.1.3 Corrective Action Program ................................................................................................................. 1‐5 1.4 Assumptions ................................................................................................................................................. 1‐6 2 Mission ................................................................................................................................................................ 2‐1 3 Concept of Operation .......................................................................................................................................... 3‐1 3.1 Operational Priorities and Objectives........................................................................................................... 3‐1 3.2 Operational Phases ....................................................................................................................................... 3‐2 3.2.1 Phase 1: Potentially Limited Doses Available ........................................................................................ 3‐5 3.2.2 Phase 2: Large Number of Doses Available, Supply Likely to Meet Demand ........................................ 3‐5 3.2.3 Phase 3: Likely Sufficient Supply, Slowing Demand .............................................................................. 3‐6 3.3 Roles and Responsibilities ............................................................................................................................ 3‐6 3.3.1 Federal ................................................................................................................................................... 3‐6 3.3.2 State ...................................................................................................................................................... 3‐8 3.3.3 Local ..................................................................................................................................................... 3‐12 3.3.4 Private and Nonprofit Sector ............................................................................................................... 3‐13 3.3.1 Phase 1: Potentially Limited Doses Available ........................................................................................ 3‐3 3.3.2 Phase 2: Large Number of Doses Available, Supply Likely to Meet Demand ........................................ 3‐5 3.3.3 Phase 3: Likely Sufficient Supply, Slowing Demand .............................................................................. 3‐5 3.4 Roles and Responsibilities ............................................................................................................................ 3‐6 3.4.1 Federal ................................................................................................................................................... 3‐6 3.4.2 State ...................................................................................................................................................... 3‐8 3.4.3 Local ..................................................................................................................................................... 3‐11 3.4.4 Private and Nonprofit Sector ............................................................................................................... 3‐12 4 Administration, Resources and Funding .............................................................................................................. 4‐1 4.1 Administration .............................................................................................................................................. 4‐1 4.1.1 Personnel Administration Management Responsibility ........................................................................ 4‐2 4.2 Resources ...................................................................................................................................................... 4‐2 4.2.1 Staffing .................................................................................................................................................. 4‐2 4.2.2 Inventory ............................................................................................................................................... 4‐3 4.3 Funding ......................................................................................................................................................... 4‐3 5 Oversight, Coordinating Instructions, and Communications .............................................................................. 5‐1 5.1. Oversight ..................................................................................................................................................... 5‐1 5.2. Communications .......................................................................................................................................... 5‐2 Appendix A: Task Organization ............................................................................................................................... A‐1 Vaccination Core Planning Team (CPT) .............................................................................................................. A‐2 Vaccination Program Implementation Committee (VPIC) ................................................................................. A‐4 Vaccine Prioritization/Allocation Working Group .............................................................................................. A‐6 Vaccine Communications Working Group .......................................................................................................... A‐6 Base Plan Table of Contents v Vaccine Medical Advisory Working Group ......................................................................................................... A‐7 Vaccine Provider Outreach and Enrollment Working Group ............................................................................. A‐7 Vaccination Program Training and Exercise Working Group ............................................................................. A‐8 Organizational Structure .................................................................................................................................... A‐9 Tab 1: Hawaii County Organizational Structure ........................................................................................... A‐17 Tab 2: Maui County Organizational Structure .............................................................................................. A‐18 Tab 3: City and County of Honolulu Organizational Structure ..................................................................... A‐19 Tab 4: Kauai County Organizational Structure ............................................................................................. A‐20 Tab